PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
Status: Recruiting
Location: See all (7) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.
Eligibility
Participation Requirements
Sex: Male
Maximum Age: 80
Healthy Volunteers: f
View:
• International Prostate Symptom Score (IPSS) ≥ 8
• Gleason Grade Group 1-3
• Prostate-specific Antigen (PSA) ≤20ng/mL
• Cancer stage less than or equal to T2c
Locations
United States
California
San Diego Clinical Trials
RECRUITING
La Mesa
Illinois
Endeavour Health (NorthShore University HealthSystem)
RECRUITING
Glenview
Texas
Urology Austin, PLLC
NOT_YET_RECRUITING
Austin
Virginia
Potomac Urology Center
RECRUITING
Alexandria
Other Locations
Hong Kong Special Administrative Region
The Chinese University of Hong Kong
RECRUITING
Hong Kong
Lebanon
American University of Beirut
RECRUITING
Beirut
New Zealand
Tauranga Urology Research Ltd
RECRUITING
Tauranga
Contact Information
Primary
Angela Lee
a.lee@procept-biorobotics.com
650-232-7215
Time Frame
Start Date: 2022-11-22
Estimated Completion Date: 2026-05
Participants
Target number of participants: 125
Treatments
Experimental: Aquablation
Related Therapeutic Areas
Sponsors
Leads: PROCEPT BioRobotics